phase 2_initiation
saveFudan University Shanghai Cancer Center — YZJ-2440 (Phase II Trial Initiation)
community read0 votes
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Solid Tumor